Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lumos Diagnostics

Explore full profile

Helps to develop and manufacture custom rapid Point-of-Care diagnostic solutions

Carlsbad, United StatesFounded 2018Health Tech & Medtech
Valuation $60M Market cap · 2026
Revenue $12M Latest reported FY
Total funding $10–50M Disclosed equity funding

About Lumos Diagnostics

Lumos Diagnostics specializes in developing, manufacturing, and commercializing custom rapid point of care (POC) diagnostic solutions. The company operates in the healthcare diagnostics market, serving clients ranging from healthcare providers to pharmaceutical companies. Lumos Diagnostics leverages its ISO 13485 certified manufacturing facility and co-located technical R&D team to minimize the time and risk associated with transferring products into production. This integrated approach ensures ongoing support and high-quality output.

Read full description

The business model of Lumos Diagnostics revolves around providing tailored diagnostic solutions that meet specific client needs. This includes the development of proprietary Lumos-branded POC diagnostic tests and assays, which can be configured as standalone manual read products or integrated with Lumos readers or third-party hardware for fully automated solutions. Additionally, Lumos has developed a digital technology platform that allows clients to utilize cloud-based services to create a comprehensive product ecosystem, enhancing the capability of diagnostic readers.

Lumos Diagnostics generates revenue through direct commercial sales of its proprietary diagnostic tests, custom development projects, and ongoing support services. By offering a combination of product sales and bespoke development services, the company ensures a diversified income stream.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Carlsbad, United States
Listing
IPO 2021
Employees
69
Open positions
1
Dealroom signal
85.1/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Client focus
b2b

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBT✓Debt Jul 2026 $3.2M — Undisclosed ↗
POST IPO EQUITY✓Other financing Apr 2026 $0 — Undisclosed ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $13M 0% −$4.5M -36.1% −$7.2M -57.5% $106K
2025 $13M +12.3% −$4.5M -36.1% −$7.2M -57.5% $106K
2024 $11M +5.7% −$4.9M -44% −$8.6M -77.2% $69K
2023 $11M -9.4% −$4.3M -40.6% $421K
2022 $12M -38.3% −$19M -160.5%
2021 $19M — — — — — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Lumos Diagnostics website traffic

Latest recorded traffic for Lumos Diagnostics is 12K monthly website visits, up 0% over the last three months. Lumos Diagnostics's team grew 15% over the past year.

Latest monthly visits12K 3-month web change0% 1-year team growth+15%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Innovation Connections

Series A2 investors entered at this stage

  • Planet Innovation
  • Regal Funds Management

Other known investors5 additional known investors

  • Australian Unity
  • Ellerston Capital
  • Perennial
  • Soul Patts
  • Tenmile
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States83.9%
🇦🇺 Australia12.5%
🇵🇰 Pakistan1.8%
🇬🇧 United Kingdom1.8%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lumos Diagnostics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lumos Diagnostics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.